Long noncoding RNA GHET1 in human cancer
Jinglin Li1, Xingming Jiang1, Zhenglong Li1
1Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, No.246 Xuefu Avenue, Harbin 150086, China.
Abstract:
LncRNAs are a group of noncoding RNAs that are >200 nucleotides in length. These RNAs have no significant protein-coding potential due to the lack of obvious open reading frames. To date, accumulating evidence has demonstrated that dysregulation of lncRNAs exhibits indispensable roles in the pathological processes of human cancers. These RNAs function as either oncogenes or tumor suppressor genes to regulate proliferation, migration and invasion of cancer cells. GHET1, a prominent oncogenic lncRNA, is highly expressed in diverse malignancies. Furthermore, GHET1 performs key functions in carcinogenesis and progression, suggesting that GHET1 is expected to be a prospective biomarker or therapeutic target for cancers. In this review, we provide a summary of the current evidence concerning the biological functions, underlying mechanisms and clinical significance of GHET1 during tumor development.
Insights
Long noncoding RNAs (lncRNAs) are crucial in cancer development. The oncogenic lncRNA GHET1 is highly expressed in malignancies and plays key roles in tumor progression, making it a potential cancer biomarker and therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides with no protein-coding potential.
- Dysregulation of lncRNAs is implicated in human cancer pathology, where they can act as oncogenes or tumor suppressors.
- GHET1 is identified as a significant oncogenic lncRNA with elevated expression across various cancers.
Purpose of the Study:
- To review the biological functions of GHET1 in cancer.
- To summarize the underlying molecular mechanisms of GHET1 in tumorigenesis.
- To discuss the clinical significance of GHET1 as a potential cancer biomarker and therapeutic target.
Main Methods:
- Literature review of studies on lncRNAs and GHET1 in cancer.
- Analysis of experimental data on GHET1 expression and function.
- Synthesis of information regarding GHET1's role in cancer cell proliferation, migration, and invasion.
Main Results:
- GHET1 is overexpressed in numerous types of cancer.
- GHET1 actively contributes to cancer initiation and progression.
- GHET1 influences key cancer cell behaviors, including proliferation, migration, and invasion.
Conclusions:
- GHET1 is a critical oncogenic lncRNA in human cancers.
- GHET1's functions in carcinogenesis highlight its potential as a biomarker.
- GHET1 represents a promising therapeutic target for various malignancies.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
RNA Stability
RNA Splicing
RNA Editing
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...


